Showing results (671-680 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|January 7, 2020
Implications of T cell receptor biology on the development of new T cell therapies for cancerIan R Hardy, Wolfgang W Schamel, Patrick A Baeuerle, et al.Immunotherapy|March 27, 2020
Immunotherapy for esophageal cancer: a 2019 updateDimitrios Schizas, Nikolaos Charalampakis, Christo Kole, et al.Immunotherapy|November 27, 2018
Risk of fatigue in cancer patients treated with anti programmed cell death-1/anti programmed cell death ligand-1 agents: a systematic review and meta-analysisMatteo Santoni, Alessandro Conti, Sebastiano Buti, et al.Immunotherapy|October 26, 2022
Surrogate end points for survival in patients with advanced hepatocellular carcinoma treated with immune checkpoint inhibitorsAndrew X Zhu, Yong Lin, David Ferry, et al.Immunotherapy|July 22, 2025
Immune checkpoint inhibitors and venous thromboembolism in patients with head and neck cancer undergoing surgeryKiranya E Arnold, Febronia M Mansour, Komal AkhtarImmunotherapy|July 13, 2025
Nivolumab induced discolouration of the tongue: a case reportElif Değirmenci Aktaş, Dilek YildirimImmunotherapy|June 2, 2025
Evaluating remibrutinib in the treatment of chronic spontaneous urticariaAgnieszka Bożek, Adam ReichImmunotherapy|May 29, 2025
Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndromeSophie Giesler, Francesca Biavasco, Tobias Wertheimer, et al.Immunotherapy|November 4, 2025
Chimeric antigen receptor natural killer (CAR-NK) cells: from preclinical promise to clinical reality in cancer immunotherapyHunter Cassidy Cochran, Kevin Ashkan Ghobadi, Armin GhobadiImmunotherapy|July 7, 2025
Rescued with T and B lymphocytes depletion therapy for immune checkpoint inhibitor-associated transplant rejectionSiqi Qiu, Zhipeng Zong, Kang HePageof 188